Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.50
15.02.24
-
15.02.25
-3.09%
17.02.24

Risky Investment
daimler1 
15.02.24 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.20
24.12.23
-
24.12.24
1.36%
06.01.24

Could be worthwhile Investment >10% per year
melinda 
24.12.23 0%
sell
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.40
24.10.23
-
24.10.24
-62.14%
28.10.23

Could be worthwhile Investment >10% per year
Global_Player 
24.10.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.23
17.09.23
-
17.09.24
-11.30%
02.10.23

Could be very worthwhile Investment >20% year
quelbe60 
17.09.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.85
03.09.23
-
03.09.24
-7.01%
16.09.23

Could be worthwhile Investment >10% per year
bundfuture 
03.09.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.98
21.08.23
-
21.08.24
-1.45%
02.09.23

Could be very worthwhile Investment >20% year
quelbe60 
21.08.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.08
07.08.23
-
07.08.24
-1.10%
19.08.23

Risky Investment
Wolf_of_WS 
07.08.23 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.03
08.07.23
-
08.07.24
-18.91%
26.11.23

Could be worthwhile Investment >10% per year
melinda 
08.07.23 10%
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.00
19.05.23
€2.20
19.05.24
-63.20%
01.10.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
geldnutzer 
19.05.23 50%
sell
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.44
30.04.23
-
30.04.24
-70.95%
01.05.24

StockNews.com 
30.04.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.43
30.04.23
-
30.04.24
-47.00%
01.05.24

StockNews.com 
30.04.23 50%
sell
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.55
22.04.23
-
22.04.24
-76.33%
23.04.24

StockNews.com 
22.04.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.41
22.04.23
-
22.04.24
-43.90%
23.04.24

StockNews.com 
22.04.23 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.80
03.04.23
-
03.04.27
-12.14%
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
03.04.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.87
24.03.23
-
24.03.24
12.58%
18.05.23

Could be very worthwhile Investment >20% year
quelbe60 
24.03.23 50%
buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.30
20.03.23
-
20.03.24
6.18%
23.03.23

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
me8 
20.03.23 0%
sell
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€4.22
11.03.23
€4.60
11.03.24
18.48%
19.05.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
geldnutzer 
11.03.23 50%
buy
Oncolytics Biotech

Start price
Target price
Perf. (%)
€1.61
06.03.23
€4.69
06.03.24
-
07.03.24

Canaccord Genuity Group Inc. 
06.03.23 50%
buy
Oncolytics Biotech

Start price
Target price
Perf. (%)
€1.61
06.03.23
-
06.03.24
-
07.03.24

Cantor Fitzgerald 
06.03.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.36
05.03.23
-
05.03.24
-35.75%
06.03.24

StockNews.com 
05.03.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.36
26.02.23
-
26.02.24
-35.75%
27.02.24

StockNews.com 
26.02.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.46
04.01.23
€12.00
31.12.25
63.49%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
04.01.23 60%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.55
03.01.23
-
03.01.24
78.44%
14.05.23

Could be worthwhile Investment >10% per year
bundfuture 
03.01.23 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.80
19.11.22
€2.00
19.11.23
-41.00%
20.11.23

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
19.11.22 50%
sell
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.05
20.09.22
€1.80
20.09.23
36.59%
19.11.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
20.09.22 50%